Blue Owl Capital Holdings LP 13D and 13G filings for AEON Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 5:09 pm Sale |
2024-12-31 | 13G | AEON Biopharma, Inc. AEON |
Blue Owl Capital Holdings LP | 42,352 3.810% |
-4,053![]() (-8.73%) |
Filing |
2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | AEON Biopharma, Inc. AEON |
Blue Owl Capital Holdings LP | 46,406 8.450% |
46,406![]() (New Position) |
Filing |